Kesios Therapeutics

About:

Kesios Therapeutics, a London, UK-based oncology drug discovery company

Top Investors: Abingworth, SV Health Investors, Imperial Innovations

Description:

Kesios Therapeutics Limited develops small molecule drugs for haematological malignancies, such as multiple myeloma and related indications. The company was incorporated in 2012 and is based in London, United Kingdom.

Total Funding Amount:

20.9M GBP

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2012-01-01

Contact Email:

info(AT)kesios.com

Founders:

Guido Franzoso, Laura Tornatore, Menotti Ruvo

Number of Employees:

1-10

Last Funding Date:

2016-08-02

IPO Status:

Private

Industries: